ACM
BEAT

AlphaCrest Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

AlphaCrest Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,808
Closed -$812K – 1333
2020
Q3 		$812K Buy
+17,808
New +$744K 0.09% 342
2019
Q4 		– Sell
-13,200
Closed -$538K – 1455
2019
Q3 		$538K Buy
13,200
+6,200
+89% +$268K 0.03% 877
2019
Q2 		$337K Buy
+7,000
New +$368K 0.03% 825

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

AlphaCrest Capital Management's BEAT Position: Q4 2020 in Review

AlphaCrest Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 17,808 shares — an estimated $812K sold.

AlphaCrest Capital Management first reported a position in BEAT in Q2 2019 and held it in 3 quarters. The position peaked at $812K in Q3 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • AlphaCrest Capital Management reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • AlphaCrest Capital Management sold 17,808 BioTelemetry, Inc. shares in Q4 2020, an estimated $812K.
  • AlphaCrest Capital Management first reported a position in BioTelemetry, Inc. in Q2 2019 and held it in 3 quarters.
  • AlphaCrest Capital Management's BioTelemetry, Inc. position peaked at $812K in Q3 2020.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on AlphaCrest Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.